Estradiol - novelty or standard in vaginal therapy?

Authors present review of articles about the use of vaginal tablets containing 25 µg of 17β-estradiol in the treatment of urogynecological complaints resulting from estrogen deficiency in peri- and postmenopausal women. Data shows that dose of 25 µg of 17β-estradiol does not have clinically signific...

Full description

Saved in:
Bibliographic Details
Published in:Przegla̜d menopauzalny 2004-09, Vol.8 (5)
Main Authors: Suzin, Jacek, Surkont, Grzegorz, Wlazlak, Edyta
Format: Article
Language:eng ; pol
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 5
container_start_page
container_title Przegla̜d menopauzalny
container_volume 8
creator Suzin, Jacek
Surkont, Grzegorz
Wlazlak, Edyta
description Authors present review of articles about the use of vaginal tablets containing 25 µg of 17β-estradiol in the treatment of urogynecological complaints resulting from estrogen deficiency in peri- and postmenopausal women. Data shows that dose of 25 µg of 17β-estradiol does not have clinically significant systemic activity. Till now, if properly used, vaginal tablet containing 25 µg of 17β-estradiol does not show stimulating activity on endometrium. Authors consider that medicaments containing estradiol ad estriol are both standards in modern vaginal estrogen therapy. Vaginal tablet containing 17β-estradiol are noticed by most of the patients as more comfortable ad hygienic than vagitories and creams.
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1237651306</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2840255321</sourcerecordid><originalsourceid>FETCH-proquest_journals_12376513063</originalsourceid><addsrcrecordid>eNqNy0sKwjAUQNEgCtbPHh44DuRT03bkQCouwHl50FRbQlLz0kJ3rwMX4OhOzl2xTKmq4kLocs0yaXLNy7IwW7YjGoQwlZJ5xnRNKWLbBwccfJitSwuECJTQtxhb6D3M-Ow9OkgvG3FcLge26dCRPf66Z6db_bje-RjDe7KUmiFM8XtQI5UuzFlqYfR_6gPj-TU6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1237651306</pqid></control><display><type>article</type><title>Estradiol - novelty or standard in vaginal therapy?</title><source>Publicly Available Content Database</source><creator>Suzin, Jacek ; Surkont, Grzegorz ; Wlazlak, Edyta</creator><creatorcontrib>Suzin, Jacek ; Surkont, Grzegorz ; Wlazlak, Edyta</creatorcontrib><description>Authors present review of articles about the use of vaginal tablets containing 25 µg of 17β-estradiol in the treatment of urogynecological complaints resulting from estrogen deficiency in peri- and postmenopausal women. Data shows that dose of 25 µg of 17β-estradiol does not have clinically significant systemic activity. Till now, if properly used, vaginal tablet containing 25 µg of 17β-estradiol does not show stimulating activity on endometrium. Authors consider that medicaments containing estradiol ad estriol are both standards in modern vaginal estrogen therapy. Vaginal tablet containing 17β-estradiol are noticed by most of the patients as more comfortable ad hygienic than vagitories and creams.</description><identifier>ISSN: 1643-8876</identifier><identifier>EISSN: 2299-0038</identifier><language>eng ; pol</language><publisher>Poznan: Termedia Publishing House</publisher><ispartof>Przegla̜d menopauzalny, 2004-09, Vol.8 (5)</ispartof><rights>Copyright Termedia Publishing House 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1237651306?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,25734,36993,44571</link.rule.ids></links><search><creatorcontrib>Suzin, Jacek</creatorcontrib><creatorcontrib>Surkont, Grzegorz</creatorcontrib><creatorcontrib>Wlazlak, Edyta</creatorcontrib><title>Estradiol - novelty or standard in vaginal therapy?</title><title>Przegla̜d menopauzalny</title><description>Authors present review of articles about the use of vaginal tablets containing 25 µg of 17β-estradiol in the treatment of urogynecological complaints resulting from estrogen deficiency in peri- and postmenopausal women. Data shows that dose of 25 µg of 17β-estradiol does not have clinically significant systemic activity. Till now, if properly used, vaginal tablet containing 25 µg of 17β-estradiol does not show stimulating activity on endometrium. Authors consider that medicaments containing estradiol ad estriol are both standards in modern vaginal estrogen therapy. Vaginal tablet containing 17β-estradiol are noticed by most of the patients as more comfortable ad hygienic than vagitories and creams.</description><issn>1643-8876</issn><issn>2299-0038</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNy0sKwjAUQNEgCtbPHh44DuRT03bkQCouwHl50FRbQlLz0kJ3rwMX4OhOzl2xTKmq4kLocs0yaXLNy7IwW7YjGoQwlZJ5xnRNKWLbBwccfJitSwuECJTQtxhb6D3M-Ow9OkgvG3FcLge26dCRPf66Z6db_bje-RjDe7KUmiFM8XtQI5UuzFlqYfR_6gPj-TU6</recordid><startdate>20040901</startdate><enddate>20040901</enddate><creator>Suzin, Jacek</creator><creator>Surkont, Grzegorz</creator><creator>Wlazlak, Edyta</creator><general>Termedia Publishing House</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BYOGL</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20040901</creationdate><title>Estradiol - novelty or standard in vaginal therapy?</title><author>Suzin, Jacek ; Surkont, Grzegorz ; Wlazlak, Edyta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_12376513063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; pol</language><creationdate>2004</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Suzin, Jacek</creatorcontrib><creatorcontrib>Surkont, Grzegorz</creatorcontrib><creatorcontrib>Wlazlak, Edyta</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>East Europe, Central Europe Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Przegla̜d menopauzalny</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Suzin, Jacek</au><au>Surkont, Grzegorz</au><au>Wlazlak, Edyta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Estradiol - novelty or standard in vaginal therapy?</atitle><jtitle>Przegla̜d menopauzalny</jtitle><date>2004-09-01</date><risdate>2004</risdate><volume>8</volume><issue>5</issue><issn>1643-8876</issn><eissn>2299-0038</eissn><abstract>Authors present review of articles about the use of vaginal tablets containing 25 µg of 17β-estradiol in the treatment of urogynecological complaints resulting from estrogen deficiency in peri- and postmenopausal women. Data shows that dose of 25 µg of 17β-estradiol does not have clinically significant systemic activity. Till now, if properly used, vaginal tablet containing 25 µg of 17β-estradiol does not show stimulating activity on endometrium. Authors consider that medicaments containing estradiol ad estriol are both standards in modern vaginal estrogen therapy. Vaginal tablet containing 17β-estradiol are noticed by most of the patients as more comfortable ad hygienic than vagitories and creams.</abstract><cop>Poznan</cop><pub>Termedia Publishing House</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1643-8876
ispartof Przegla̜d menopauzalny, 2004-09, Vol.8 (5)
issn 1643-8876
2299-0038
language eng ; pol
recordid cdi_proquest_journals_1237651306
source Publicly Available Content Database
title Estradiol - novelty or standard in vaginal therapy?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T01%3A17%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Estradiol%20-%20novelty%20or%20standard%20in%20vaginal%20therapy?&rft.jtitle=Przegla%CC%9Cd%20menopauzalny&rft.au=Suzin,%20Jacek&rft.date=2004-09-01&rft.volume=8&rft.issue=5&rft.issn=1643-8876&rft.eissn=2299-0038&rft_id=info:doi/&rft_dat=%3Cproquest%3E2840255321%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_12376513063%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1237651306&rft_id=info:pmid/&rfr_iscdi=true